Splenic uptake of Tc-99m MDP in patients with hematologic abnormalities recently treated with chemotherapy.
Howarth
D
D
Department of Nuclear Medicine, John Hunter Hospital, NSW, Australia.
Thomas
P
P
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001842:Bone and Bones / Q000000981:diagnostic imaging; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013154:Spleen / Q000000981:diagnostic imaging*; D013669:Technetium Tc 99m Medronate
D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate